Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
April 23, 2019
Patent Application Number
15424621
Date Filed
February 3, 2017
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to agents that modulate interleυkin-15 (“IL-15”) signal transduction or function (“Therapeutic Agents”) and the use ol” those agents to modulate immune function. The Therapeutic Agents target the interaction between IL-15 and its receptor and modulate IL-15-induced signal transduction. The Therapeutic Agents may be formulated with polymers, such as poly-β-1-♦4-N-acetylglucosamine. for administration to a human subject to modulate IL-15-mediated immune function.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
